ARTICLE | Company News
Domain Therapeutics, Mavalon Therapeutics deal
October 24, 2016 7:00 AM UTC
Domain formed single-asset, U.K.-based newco Mavalon Therapeutics with an investment of up to EUR9 million ($9.9 million) from Medicxi Ventures. Domain also granted Mavalon rights to positive alloster...